These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21742807

  • 21. Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
    Bornhauser BC, Bonapace L, Lindholm D, Martinez R, Cario G, Schrappe M, Niggli FK, Schäfer BW, Bourquin JP.
    Blood; 2007 Sep 15; 110(6):2084-91. PubMed ID: 17537996
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.
    Gupta M, Ansell SM, Novak AJ, Kumar S, Kaufmann SH, Witzig TE.
    Blood; 2009 Oct 01; 114(14):2926-35. PubMed ID: 19641186
    [Abstract] [Full Text] [Related]

  • 23. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
    Yang JX, Hsieh KC, Chen YL, Lee CK, Conti M, Chuang TH, Wu CP, Jin SC.
    Sci Rep; 2017 Apr 06; 7():46165. PubMed ID: 28383060
    [Abstract] [Full Text] [Related]

  • 24. Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.
    McGirr A, Lipina TV, Mun HS, Georgiou J, Al-Amri AH, Ng E, Zhai D, Elliott C, Cameron RT, Mullins JG, Liu F, Baillie GS, Clapcote SJ, Roder JC.
    Neuropsychopharmacology; 2016 Mar 06; 41(4):1080-92. PubMed ID: 26272049
    [Abstract] [Full Text] [Related]

  • 25. Cyclic-AMP signalling, MYC and hypoxia-inducible factor 1α intersect to regulate angiogenesis in B-cell lymphoma.
    Ethiraj P, Sasi B, Holder KN, Lin AP, Qiu Z, Jaafar C, Elkhalili A, Desai P, Saksena A, Ritter JP, Aguiar RCT.
    Br J Haematol; 2022 Jul 06; 198(2):349-359. PubMed ID: 35411936
    [Abstract] [Full Text] [Related]

  • 26. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
    Ni T, Wang H, Li D, Tao L, Lv M, Jin F, Wang W, Feng J, Qian Y, Sunagawa M, Liu Y.
    Biomed Pharmacother; 2019 Oct 06; 118():109241. PubMed ID: 31351435
    [Abstract] [Full Text] [Related]

  • 27. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.
    Avila DV, Barker DF, Zhang J, McClain CJ, Barve S, Gobejishvili L.
    J Pathol; 2016 Sep 06; 240(1):96-107. PubMed ID: 27287961
    [Abstract] [Full Text] [Related]

  • 28. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
    Yang J, Li Y, Zhang Y, Fang X, Chen N, Zhou X, Wang X.
    J Exp Clin Cancer Res; 2020 Jul 25; 39(1):142. PubMed ID: 32711549
    [Abstract] [Full Text] [Related]

  • 29. Phosphodiesterase 4b expression plays a major role in alcohol-induced neuro-inflammation.
    Avila DV, Myers SA, Zhang J, Kharebava G, McClain CJ, Kim HY, Whittemore SR, Gobejishvili L, Barve S.
    Neuropharmacology; 2017 Oct 25; 125():376-385. PubMed ID: 28807677
    [Abstract] [Full Text] [Related]

  • 30. Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D.
    Kim HW, Ha SH, Lee MN, Huston E, Kim DH, Jang SK, Suh PG, Houslay MD, Ryu SH.
    Mol Cell Biol; 2010 Nov 25; 30(22):5406-20. PubMed ID: 20837708
    [Abstract] [Full Text] [Related]

  • 31. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
    Hall CP, Reynolds CP, Kang MH.
    Clin Cancer Res; 2016 Feb 01; 22(3):621-32. PubMed ID: 26080839
    [Abstract] [Full Text] [Related]

  • 32. Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.
    Pham LV, Huang S, Zhang H, Zhang J, Bell T, Zhou S, Pogue E, Ding Z, Lam L, Westin J, Davis RE, Young KH, Medeiros LJ, Ford RJ, Nomie K, Zhang L, Wang M.
    Clin Cancer Res; 2018 Aug 15; 24(16):3967-3980. PubMed ID: 29666304
    [Abstract] [Full Text] [Related]

  • 33. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
    Mishra RR, Belder N, Ansari SA, Kayhan M, Bal H, Raza U, Ersan PG, Tokat ÜM, Eyüpoğlu E, Saatci Ö, Jandaghi P, Wiemann S, Üner A, Cekic C, Riazalhosseini Y, Şahin Ö.
    Clin Cancer Res; 2018 Apr 15; 24(8):1987-2001. PubMed ID: 29386221
    [Abstract] [Full Text] [Related]

  • 34. Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression.
    Zhang W, Li Q, Yang C, Yang H, Rao J, Zhang X.
    Biochem Biophys Res Commun; 2020 Mar 26; 524(1):70-76. PubMed ID: 31980182
    [Abstract] [Full Text] [Related]

  • 35. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells.
    Ghorbani A, Jeddi-Tehrani M, Saidpour A, Safa M, Bayat AA, Zand H.
    Arch Biochem Biophys; 2015 Jan 15; 566():58-66. PubMed ID: 25524737
    [Abstract] [Full Text] [Related]

  • 36. Glucocorticoid-induced CREB activation and myostatin expression in C2C12 myotubes involves phosphodiesterase-3/4 signaling.
    Xie Y, Perry BD, Espinoza D, Zhang P, Price SR.
    Biochem Biophys Res Commun; 2018 Sep 10; 503(3):1409-1414. PubMed ID: 30025893
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
    Xu M, Yu X, Meng X, Huang S, Zhang Y, Zhang A, Jia Z.
    Am J Physiol Renal Physiol; 2020 Mar 01; 318(3):F576-F588. PubMed ID: 31961716
    [Abstract] [Full Text] [Related]

  • 38. PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.
    Chen J, Ge X, Zhang W, Ding P, Du Y, Wang Q, Li L, Fang L, Sun Y, Zhang P, Zhou Y, Zhang L, Lv X, Li L, Zhang X, Zhang Q, Xue K, Gu H, Lei Q, Wong J, Hu W.
    Theranostics; 2020 Mar 01; 10(7):3151-3163. PubMed ID: 32194860
    [Abstract] [Full Text] [Related]

  • 39. MCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphoma.
    Lee JS, Tang SS, Ortiz V, Vo TT, Fruman DA.
    Oncotarget; 2015 Nov 03; 6(34):35202-17. PubMed ID: 26460954
    [Abstract] [Full Text] [Related]

  • 40. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
    Peng YK, Pu K, Su HX, Zhang J, Zheng Y, Ji R, Guo QH, Wang YP, Guan QL, Zhou YN.
    Eur Rev Med Pharmacol Sci; 2020 Feb 03; 24(3):1142-1151. PubMed ID: 32096170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.